Related Experiment Video
Updated: Apr 29, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Obesity associated with type 2 diabetes mellitus is linked to decreased PC1/3 mRNA expression in the Jejunum
Francieli Rohden1, Cintia S Costa, Thais O Hammes
1Departamento de Bioquímica, ICBS, UFRGS, Rua Ramiro Barcelos 2600 - anexo, CEP 90.035-003, Porto Alegre, RS, Brazil.
Background:
Bariatric surgery is the most effective therapeutic option for obesity and its complications, especially in type 2 diabetes. The aim of this study was to investigate the messenger RNA (mRNA) gene expression of proglucagon, glucose-dependent insulinotropic peptide (GIP), prohormone convertase 1/3 (PC1/3), and dipeptidyl peptidase-IV (DPP-IV) in jejunum cells of the morbidly obese (OB) non type 2 diabetes mellitus (NDM2) and type 2 diabetes mellitus (T2DM), to determine the molecular basis of incretin secretion after bariatric surgery.
Methods:
Samples of jejunal mucosa were obtained from 20 NDM2 patients: removal of a section of the jejunum about 60 cm distal to the ligament of Treitz and 18 T2DM patients: removal of a section of the jejunum about 100 cm distal to the ligament of Treitz. Total RNA was extracted using TRIzol. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was carried out. Samples were sequenced to PC1/3 by ACTGene Análises Moleculares Ltd. Immuno content was quantified with a fluorescence microscope.
Results:
T2DM showed decreased PC1/3 mRNA expression in the primers tested (primer a, p=0.014; primer b, p=0.048). Many patients (36.5 %) did not express PC1/3 mRNA. NDM2 and T2DM subjects showed nonsignificantly different proglucagon, GIP, and DPP-IV mRNA expression. The immuno contents of glucagon-like peptide-1 and GIP decreased in T2DM jejunum, but incubation with high glucose stimulated the immuno contents.
Conclusions:
The results suggest that bioactivation of pro-GIP and proglucagon could be impaired by the lower expression of PC1/3 mRNA in jejunum cells of obese patients with T2DM. However, after surgery, food could activate this system and improve glucose levels in these patients.
Insights
Obese patients with type 2 diabetes have impaired prohormone convertase 1/3 (PC1/3) mRNA expression in the jejunum. Bariatric surgery may improve glucose levels by activating this system.
Area of Science:
- Endocrinology
- Molecular Biology
- Gastroenterology
Background:
- Bariatric surgery is a highly effective treatment for obesity and type 2 diabetes.
- Incretin hormones play a crucial role in glucose regulation.
- Understanding the molecular basis of incretin secretion is vital for managing obesity and diabetes.
Purpose of the Study:
- To investigate messenger RNA (mRNA) gene expression of key incretin-related molecules in the jejunum of obese patients with and without type 2 diabetes.
- To explore the molecular underpinnings of incretin secretion in the context of bariatric surgery.
Main Methods:
- Jejunal mucosa samples were collected from non-diabetic (NDM2) and type 2 diabetic (T2DM) obese patients.
- Messenger RNA (mRNA) expression levels of proglucagon, GIP, PC1/3, and DPP-IV were analyzed using RT-qPCR.
- Immuno content of GLP-1 and GIP was quantified via fluorescence microscopy.
Main Results:
- Type 2 diabetes patients exhibited significantly decreased prohormone convertase 1/3 (PC1/3) mRNA expression in the jejunum.
- Proglucagon, GIP, and DPP-IV mRNA expression levels were not significantly different between NDM2 and T2DM groups.
- Glucagon-like peptide-1 and GIP immuno content decreased in T2DM jejunum, but high glucose stimulated these levels.
Conclusions:
- Reduced PC1/3 mRNA expression in the jejunum may impair the bioactivation of pro-GIP and proglucagon in obese patients with T2DM.
- Bariatric surgery could potentially enhance incretin secretion and improve glucose control in these patients by activating this system.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Cell Specific Gene Expression
Obesity
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

